Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GREM1 |
| Upstream (Parents) |
|---|
| (<<) SULF1 → GREM1 |
| (<<) COL1A2 → GREM1 |
| (<<) ACTA2 → GREM1 |
| Downstream (Children) |
|---|
| GREM1 → UNGP2 (>>) |
| GREM1 → HTR4 (>>) |
| GREM1 → SMNP (>>) |
| GREM1 → PLCL1 (>>) |
| GREM1 → ADM2 (>>) |
| GREM1 → CCL8 (>>) |
| GREM1 → ROS1 (>>) |
| GREM1 → LPL (>>) |
| GREM1 → DUSP4 (>>) |
| GREM1 → C9orf68 (>>) |
| GREM1 → CCL11 (>>) |
| GREM1 → CDR2L (>>) |
| GREM1 → CRYM (>>) |
